Tero Vahlberg

Tero Vahlberg

Auto-generated profile, based on publicly available information

Tero Vahlberg

Department of Biostatistics, University of Turku, Turku, Finland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2017 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
VKValtteri Kaasinen
Valtteri Kaasinen
TVTero Vahlberg
Tero Vahlberg

21 February 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
KKKati Anneli Kannisto
Kati Anneli Kannisto
JKJoonas Korhonen
Joonas Korhonen
CAClive E Adams
Clive E Adams
MKMarita Hannele Koivunen
Marita Hannele Koivunen
TVTero Vahlberg
Tero Vahlberg
MVMaritta Anneli Välimäki
Maritta Anneli Välimäki
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 August 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
SLSinikka Luutonen
Sinikka Luutonen
TVTero Vahlberg
Tero Vahlberg
SESini Eloranta
Sini Eloranta
HHHeidi Hyväri
Heidi Hyväri
ESEeva Salminen
Eeva Salminen

14 January 2017 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MKMax Karukivi
Max Karukivi
TVTero Vahlberg
Tero Vahlberg
KHKalle Horjamo
Kalle Horjamo
MNMinna Nevalainen
Minna Nevalainen
JKJyrki Korkeila
Jyrki Korkeila
Current categorical classification of personality disorders has been criticized for overlooking the dimensional nature of personality and that it may miss some sub-threshold personality disturbances of clinical significance. We aimed to evaluate the clinical importance of these conditions. For this, we used a simple four-level dimensional categorization based on the severity of personality disturbance. The sample consisted of 352 patients admitted to mental health services. All underwent diagnostic assessments (SCID-I and SCID-II) and filled in questionnaires concerning their social situation and childhood adversities, and other validated tools, including the Beck Depression Inventory (BDI), Alcohol Use Disorders Identification Test (AUDIT), health-related quality of life (15D), and the five-item Mental Health Index (MHI-5). The patients were categorized into four groups according to the level of personality disturbance: 0 = No personality disturbance, 1 = Personality difficulty (one criterion less than threshold for one or more personality disorders), 2 = Simple personality disorder (one personality disorder), and 3 = Complex/Severe personality disorder (two or more personality disorders or any borderline and antisocial personality disorder). The proportions of the groups were as follows: no personality disturbance 38.4% (n = 135), personality difficulty 14.5% (n = 51), simple personality disorder 19.9% (n = 70), and complex/severe personality disorder 24.4% (n = 86). Patients with no personality disturbance were significantly differentiated (p < 0.05) from the other groups regarding the BDI, 15D, and MHI-5 scores as well as the number of Axis I diagnoses. Patients with complex/severe personality disorders stood out as being worst off. Social dysfunction was related to the severity of the personality disturbance. Patients with a personality difficulty or a simple personality disorder had prominent symptoms and difficulties, but the differences between these groups were mostly non-significant. An elevated severity level of personality disturbance is associated with an increase in psychiatric morbidity and social dysfunction. Diagnostically sub-threshold personality difficulties are of clinical significance and the degree of impairment corresponds to actual personality disorders. Since these two groups did not significantly differ from each other, our findings also highlight the complexity related to the use of diagnostic thresholds for separate personality disorders.

26 April 2007 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
SVSari Vaapio
Sari Vaapio
MSMarika Salminen
Marika Salminen
TVTero Vahlberg
Tero Vahlberg
NSNoora Sjösten
Noora Sjösten
RIRaimo Isoaho
Raimo Isoaho
SKSirkka-Liisa Kivelä
Sirkka-Liisa Kivelä
This study aimed to assess the effects of a risk-based, multifactorial fall prevention programme on health-related quality of life among the community-dwelling aged who had fallen at least once during the previous 12 months.

1 November 2011 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JPJuha Puustinen
Juha Puustinen
JNJanne Nurminen
Janne Nurminen
MLMinna Löppönen
Minna Löppönen
TVTero Vahlberg
Tero Vahlberg
RIRaimo Isoaho
Raimo Isoaho
SKSirkka-Liisa Kivelä
Sirkka-Liisa Kivelä
Previous studies have found associations between the use of central nervous system medication and the risk of cognitive decline in the aged. Our aim was to assess whether the use of a single central nervous system (CNS) medication and, on the other hand, the combined use of multiple CNS medications over time are related to the risk of cognitive decline in an older (≥ 65 yrs) population that is cognitively intact at baseline.